Literature DB >> 9402348

Helicobacter pylori gastritis, peptic ulcer, and gastric cancer: clinical and molecular aspects.

C S Goodwin1.   

Abstract

Helicobacter pylori causes specific ultrastructural changes to the gastric mucosa. In developing countries a high percentage of infants acquire this infection, which initially causes a transient drop in stomach acid and thus allows transit of lower bowel pathogens, with consequent diarrhea and malnutrition. When infection occurs at an early age, the acid-producing cells of the stomach are involved in the inflammation, and the lifelong reduced acid output means a duodenal ulcer rarely develops. However, lifelong gastric inflammation leads in due course to atrophy, and in the presence of other factors gastric cancer may develop. People infected with H. pylori on average are of shorter stature than uninfected people. Adherence of H. pylori to the gastric mucosa is a prerequisite for infection, and a new binary model of adherence has been shown recently. Chaperonins of H. pylori induce macrophages to secrete cytokines, which leads to an immunologic cascade and inflammation.

Entities:  

Mesh:

Year:  1997        PMID: 9402348     DOI: 10.1086/516077

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Involvement of the HP0165-HP0166 two-component system in expression of some acidic-pH-upregulated genes of Helicobacter pylori.

Authors:  Yi Wen; Jing Feng; David R Scott; Elizabeth A Marcus; George Sachs
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

2.  Identification of target genes regulated by the two-component system HP166-HP165 of Helicobacter pylori.

Authors:  Patricia Dietz; Gabriele Gerlach; Dagmar Beier
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

3.  Helicobacter pylori 5'ureB-sRNA, a cis-encoded antisense small RNA, negatively regulates ureAB expression by transcription termination.

Authors:  Yi Wen; Jing Feng; George Sachs
Journal:  J Bacteriol       Date:  2012-10-26       Impact factor: 3.490

4.  A new crystal lattice structure of Helicobacter pylori neutrophil-activating protein (HP-NAP).

Authors:  Osamu Tsuruta; Hideshi Yokoyama; Satoshi Fujii
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-01-25

5.  Helicobacter pylori intrafamilial infections: change in source of infection of a child from father to mother after eradication therapy.

Authors:  I Taneike; Y Tamura; T Shimizu; Y Yamashiro; T Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

6.  Fusion expression of Helicobacter pylori neutrophil-activating protein in E.coli.

Authors:  Qiao-Zhen Kang; Guang-Cai Duan; Qing-Tang Fan; Yuan-Lin Xi
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

7.  A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori.

Authors:  N Tsutsui; I Taneike; T Ohara; S Goshi; S Kojio; N Iwakura; H Matsumaru; N Wakisaka-Saito; H M Zhang; T Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Two-component systems of Helicobacter pylori contribute to virulence in a mouse infection model.

Authors:  Klaus Panthel; Patricia Dietz; Rainer Haas; Dagmar Beier
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.

Authors:  Amedeo Amedei; Andrea Cappon; Gaia Codolo; Anna Cabrelle; Alessandra Polenghi; Marisa Benagiano; Elisabetta Tasca; Annalisa Azzurri; Mario Milco D'Elios; Gianfranco Del Prete; Marina de Bernard
Journal:  J Clin Invest       Date:  2006-03-16       Impact factor: 14.808

10.  Screening and identification of natural antisense transcripts in Helicobacter pylori by a novel approach based on RNase I protection assay.

Authors:  Bin Xiao; Wei Li; Gang Guo; Bo-Sheng Li; Zhen Liu; Bin Tang; Xu-Hu Mao; Quan-Ming Zou
Journal:  Mol Biol Rep       Date:  2008-12-23       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.